Menu Close

Why American Men Care More About Testosterone Than Annual Checkups

Man with handful of pills on sofa indoors
Health

Online treatment and performance-focused services are attracting attention and spending. But figures cited on men’s access to ordinary healthcare raise a more important question: what happens beyond the consultation that brought them through the door?

Share this article

The men’s health market is having its biggest moment in years. Hormone clinics are scaling at warp speed, digital health platforms are posting high revenues, and a generation of men is spending real capital on their bodies.

But there is a glaring blind spot: while men are opening their wallets for optimisation, they are completely skipping the primary care physician. The gap between performance and prevention is wider than the industry wants to admit.

The Performance Boom: By the Numbers

Testosterone Replacement Therapy TRT - Muscular man applying testosterone gel on shoulder
© Marc Bruxelle | Dreamstime.com

The commercial infrastructure around male performance health is expanding faster than at any point in recent memory.

  • The Telehealth Titan: Hims & Hers reported $2.35 billion in revenue for 2025 (a 59% year-over-year increase), fueled by its 2.5 million subscribers and a massive expansion into oral and injectable testosterone categories.
  • The TRT Surge: Testosterone replacement therapy prescriptions jumped from 7.3 million in 2019 to over 11 million in 2024.
  • The Regulatory Shift: The FDA indicated it may broaden approved TRT use to cover low libido in men with idiopathic hypogonadism.

This boom has done something genuinely useful: it pulled men into a healthcare conversation they were previously opting out of. The problem? Optimisation and preventive care are not the same thing.

Where Male Healthcare Engagement Stops

Despite the wellness boom, routine care remains a massive blind spot. Recent data highlights a striking contradiction in male consumer behaviour:

  • The Care Gap: Only 87.1% of men report having a usual place to go when sick, compared to 93.3% of women.
  • Missing the Clinic: Of those who do have a spot, just 72.6% of men use an actual doctor’s office or health center, versus 82.2% of women.
  • The Waiting Game: A full 65% of men admit they put off seeing a doctor as long as possible, 60% of men say they do not see a doctor regularly, and half don’t consider an annual checkup part of self-care.
  • Emergency Default: Even worse, 2% of men name a hospital emergency room as their primary care source.

“Men are not avoiding healthcare because they don’t care about their health,” says Jaylin, Founder of Sodalemon. “They are avoiding the specific kind of care that requires sitting in a waiting room with no immediate performance benefit on the other side of it. That distinction is the real problem.”

The Fatal Cost of Skipping the Room

A routine physical catches what men can’t feel. Hypertension, diabetes, high cholesterol, and early-stage cardiovascular disease develop silently over the years. Without an annual checkup, they accumulate undetected until a crisis forces an emergency room visit.

At the far end of that spectrum is cancer. The projections paint a stark picture:

  • 1,094,070 new cancer cases projected in men, versus 1,020,780 in women.
  • 327,290 projected cancer deaths in men, versus 298,850 in women.
  • Colorectal and prostate cancers, two of the leading killers, are highly treatable when caught early.

The difference between survival and mortality isn’t medicine; it’s detection, and detection requires an appointment.

Redefining Men’s Health: From Optimisation to Longevity

The performance market proves that men do care about health when it comes to energy, strength, appearance, and output. The challenge for the industry now is to apply that exact same motivation to the screenings and checkups that actually keep men alive.

“Men are investing in how they perform today while skipping the care that determines whether they are around to perform tomorrow,” Jaylin emphasises. “The infrastructure and the attention are both there. The conversation just needs to move from optimisation to longevity.”